Posted on

growing marijuana in minnesota

MDH news releases are posted on Facebook, Twitter, and are subscribable via email and RSS feed. See the links above.

The new delivery method will become effective Aug. 1, 2022. A rulemaking process that will outline requirements for labeling, safety messaging, packaging, and testing will launch this month. Current permitted delivery forms include pills, vapor oil, liquids, topicals, powdered mixtures, and orally dissolvable products, like lozenges.

“Expanding delivery methods to gummies and chews will mean more options for patients who cannot tolerate current available forms of medical cannabis,” said Minnesota Commissioner of Health Jan Malcolm.

Coming in March 2022, registered medical cannabis patients will also be eligible for dried raw, smokable cannabis, which was approved by the 2021 Minnesota Legislature. Rulemaking for dried raw cannabis is also currently in process.

Get MDH News Releases

The Minnesota Department of Health (MDH) today announced that it will approve infused edibles in the form of gummies and chews as a new medical cannabis delivery method in the state’s medical cannabis program.

“We received many comments from health care practitioners treating patients with anxiety disorder, and they urged us to not approve it as a qualifying medical condition,” said Commissioner Malcolm. “We recognize that not everyone has equal access to therapy – which is considered the front-line treatment – but ultimately we concluded that the risk of additional harms to patients outweighed perceived benefits.”

When the Minnesota Legislature authorized the creation of the state’s medical cannabis program, the law included nine conditions that qualified a patient to receive medical cannabis. Since then, the list of conditions has grown to 17. According to state rules, the commissioner of health each year considers whether to add conditions and delivery methods.

No new conditions were added this year. As in past years, MDH conducted a formal petition and comment process to solicit public input on potential qualifying medical conditions and delivery methods for medicine. Since 2016, petitioners have requested anxiety disorder or panic disorder as a qualifying medical condition. Each year it was denied due to lack of clinical evidence and the desire to avoid any unintended consequences. This year at the request of Commissioner Malcolm, the MDH Office of Medical Cannabis conducted an in-depth review, which included a research review of anxiety disorder as a qualifying medical condition. Ultimately the addition was not approved due to a lack of scientific evidence to support effectiveness as well as concerns expressed by health care practitioners.

651-201-5000 Phone
888-345-0823 Toll-free

The MDA is required to collect annual fees for registration of sites and certification of hemp crops through THC testing. All fees are non-refundable and non-transferrable. There is a $50 fee for all license changes made after the initial application period. Such changes include changing the license holder’s name, adding a grower or processor category, and adding or changing grow or processing locations. All changes must be made by submitting a Change Request Form.

2022 Minnesota Hemp Program Application
Please click on the Hemp Licensing option from the drop-down menu.

The application period for 2022 will close on April 30, 2022.

If you are a current license holder and need to add or change locations, submit a Change Request Form. If you need to request an inspection/THC test, please contact the MDA Hemp Program.

The application period for the 2022 Minnesota Hemp Program license is now open.

First-time applicants need to submit fingerprints and pass a criminal background check. The MDA program staff will send all first-time applicants a blank fingerprint card and instructions on how to request the background check after the application is completed. Any applicant with a controlled substance-related felony conviction in the previous 10-year period will not be eligible for licensure.


2022 FEES

Growing marijuana in minnesota

“We feel we’ve had an inclusive process and we’re on track to meet the statutory requirement of March 1 or sooner,” said Chris Tholkes, director of the state Office of Medical Cannabis. “We feel like we will have good protections around the product for our patients.”

Still, it took three legislative sessions to amend the program , despite bipartisan legislative support. Schroeder said a key endorsement came from the two companies licensed to produce marijuana products: Green Goods and Leafline Labs .

Teske described that amount as being “middle of the road” among states.